| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 09/20/2011 | CA2377977C Conjugates and methods for the production thereof, and their use for transporting molecules via biological membranes |
| 09/20/2011 | CA2369848C Human endogenous retrovirus in breast cancer |
| 09/20/2011 | CA2367149C Combination of antibiotic and nucleic acid binding compound for bacterial antibiotic resistance |
| 09/20/2011 | CA2360758C 1-deoxy-d-xylulose-5-phosphate reductoisomerases, and methods of use |
| 09/20/2011 | CA2347248C Surfactant protein d for the prevention and diagnosis of pulmonary emphysema |
| 09/20/2011 | CA2329137C Novel tumor antigen useful in diagnosis and therapy of prostrate and colon cancer |
| 09/20/2011 | CA2319700C Methods of identifying genes involved in enhanced wound healing in mice |
| 09/20/2011 | CA2262403C Biomarkers and targets for diagnosis, prognosis and management of prostate disease |
| 09/20/2011 | CA2259144C Inhibition of chronic myelogenous leukemic cell growth by liposomal-antisense oligodeoxy-nucleotides targeting to grb2 or crk1 |
| 09/20/2011 | CA2115828C Calcium receptor active molecules |
| 09/15/2011 | WO2011113054A2 Crosslinked polynucleotide structure |
| 09/15/2011 | WO2011113047A2 Compositions and methods for characterizing breast cancer |
| 09/15/2011 | WO2011113043A2 Sample storage for molecular and immunological detection |
| 09/15/2011 | WO2011113030A2 Human cancer micro-rna expression profiles predictive of chemo-response |
| 09/15/2011 | WO2011113004A2 Markers associated with alzheimer's disease |
| 09/15/2011 | WO2011112980A2 Innate immunity markers of cancer |
| 09/15/2011 | WO2011112974A1 Method and system for the safety, analysis and supervision of insulin pump action and other modes of insulin delivery in diabetes |
| 09/15/2011 | WO2011112966A1 Bioluminescent assays using cyanobenzothiazole compounds |
| 09/15/2011 | WO2011112961A1 Methods and compositions for characterizing autism spectrum disorder based on gene expression patterns |
| 09/15/2011 | WO2011112929A2 Magnetic sensor based quantitative binding kinetics analysis |
| 09/15/2011 | WO2011112908A2 Optical particle characterization system |
| 09/15/2011 | WO2011112903A2 Quantitative rt-pcr detection for genes involved in epithelial mesenchymal transition in peripheral blood of breast cancer patients |
| 09/15/2011 | WO2011112901A2 Hypermethylation biomarkers for detection of cervical cancer |
| 09/15/2011 | WO2011112880A2 Hypermethylation biomarkers for detection of head and neck squamous cell cancer |
| 09/15/2011 | WO2011112827A2 Amplifying rare cell surface markers |
| 09/15/2011 | WO2011112718A1 Production of single-stranded circular nucleic acid |
| 09/15/2011 | WO2011112678A1 Methods of diagnosing and treating cancer in patients having or developing resistance to a first cancer therapy |
| 09/15/2011 | WO2011112634A2 Molecular indicia of cellular constituents and resolving the same by super-resolution technologies in single cells |
| 09/15/2011 | WO2011112586A2 Methods for diagnosing feline coronavirus infections |
| 09/15/2011 | WO2011112581A1 Androgen receptor isoforms and methods |
| 09/15/2011 | WO2011112534A1 Full cold-pcr enrichment with reference blocking sequence |
| 09/15/2011 | WO2011112397A2 Mrna as biomarkers for liver injury or other liver perturbations |
| 09/15/2011 | WO2011112245A1 Luciferase-linked analysis of dna-methyltransferase, protein methyltransferase and s-adenosylhomocysteiene and uses thereof |
| 09/15/2011 | WO2011112106A2 Urease test for detecting helicobacter pylori bacteria |
| 09/15/2011 | WO2011112085A1 ACTIVITY BASED PROBES (ABPs) INTERACTING WITH GLYCOSIDASES |
| 09/15/2011 | WO2011112068A1 Lateral flow device and method of detection of nucleic acid sequence |
| 09/15/2011 | WO2011111874A1 Cell membrane-permeating dumbbell-type rna and method for producing the same |
| 09/15/2011 | WO2011111832A1 Method for selecting polypeptide sequence, metal oxide or silicon containing compound binding peptide and use thereof |
| 09/15/2011 | WO2011111820A1 Diagnostic marker for lung cancer or cervical cancer |
| 09/15/2011 | WO2011111790A1 Production of enteritis evoking causal factor by highly pathogenic oral bacteria and high sensitivity detection method therefor |
| 09/15/2011 | WO2011111715A1 Nucleic acid capable of regulating cell cycle |
| 09/15/2011 | WO2011111698A1 MONOCLONAL ANTIBODY AGAINST NECROSIS MARKER ERp29 AND USE THEREOF |
| 09/15/2011 | WO2011111694A1 Monoclonal antibody against necrosis marker prdx4 and use thereof |
| 09/15/2011 | WO2011111614A1 Method of selecting induced pluripotent stem cell |
| 09/15/2011 | WO2011111060A1 A METHOD TO ENHANCE MULTIPLE ABIOTIC STRESS TOLERANCE OF CROP PLANTS BY OVER-EXPRESSION OF CYSTATHIONINE-β-SYNTHASE DOMAIN CONTAINING GENE AND CYSTATHIONINE-β-SYNTHASE DOMAIN CONTAINING GENE THEREFOR |
| 09/15/2011 | WO2011110873A1 Detection of methylated dna |
| 09/15/2011 | WO2011110751A1 A method, an arrangement and a computer program product for analysing a biological or medical sample |
| 09/15/2011 | WO2011110644A1 Detection and quantification of micrornas in the circulation and the use of circulating micrornas as biomarkers for cancer |
| 09/15/2011 | WO2011110367A2 Method of screening for htra protease inhibitors useful for prophylaxis and therapy of a bacterial infection |
| 09/15/2011 | WO2011110202A1 Method for the electrochemical measurement of an analyte concentration in vivo, and fuel cell for this purpose |
| 09/15/2011 | WO2011109901A1 Detection and quantification of viable bacteria in a sample using rpos mrna |
| 09/15/2011 | WO2011109884A1 Carbon-absorption photobioreactor |
| 09/15/2011 | WO2011082200A8 Tool for diagnosis and prognosis of mature b-cell neoplasms |
| 09/15/2011 | WO2011076132A8 Sequence calibration method and sequence calibration device |
| 09/15/2011 | WO2011076130A8 Method and apparatus for compressing nucleotide sequence data |
| 09/15/2011 | WO2011073675A3 Assay for detecting chlamydia trachomatis |
| 09/15/2011 | WO2011063324A3 Microfluidic systems for isolating microvesicles |
| 09/15/2011 | WO2011028041A3 Td probe and its uses |
| 09/15/2011 | WO2009156162A8 Genome wide visual identification of human co-factors of hiv-1 infection |
| 09/15/2011 | US20110225680 Methods for removal of specific seed tissue or structure for seed analysis |
| 09/15/2011 | US20110225678 Rice promoters for regulation of plant expression |
| 09/15/2011 | US20110225665 Stable dw3 Allele for Sorghum and a Molecular Marker to Facilitate Selection |
| 09/15/2011 | US20110224911 Methods and materials for canine breed identification |
| 09/15/2011 | US20110224574 Methods and systems for tissue processing and imaging |
| 09/15/2011 | US20110224512 INTRACELLULAR pH IMAGING METHOD AND APPARATUS USING FLURESCENCE LIFETIME |
| 09/15/2011 | US20110224417 Novel mixtures for assaying nucleic acid, novel method of assaying nucleic acid with the use of the same and nucleic acid probe to be used therefore |
| 09/15/2011 | US20110224406 Interleukin-9 receptor mutants |
| 09/15/2011 | US20110224313 Compositions and methods for classifying lung cancer and prognosing lung cancer survival |
| 09/15/2011 | US20110224286 MICRO RNA (MiRNA) AND NEUROFIBROMATOSIS TYPE 1: A ROLE IN DIAGNOSIS AND THERAPY |
| 09/15/2011 | US20110224279 Anticancer agent |
| 09/15/2011 | US20110224267 Selective androgen receptor modulators |
| 09/15/2011 | US20110224243 FZD2 Molulators in the Treatment of Alopecia |
| 09/15/2011 | US20110224197 Pyrimidines and pyridines useful as inhibitors of protein kinases |
| 09/15/2011 | US20110224153 Asthma Associated Factors as Targets for Treating Atopic Allergies Including Asthma and Related Disorders |
| 09/15/2011 | US20110224149 Polynucleotides for use in treating and diagnosing cancers |
| 09/15/2011 | US20110224144 Compositions and methods for diagnosing and treating mental disorders |
| 09/15/2011 | US20110224135 Use of conkunitzin-s1 for the modulation of glucose-induced insulin secretion |
| 09/15/2011 | US20110224105 Methods, compositions, and kits for generating nucleic acid products substantially free of template nucleic acid |
| 09/15/2011 | US20110224104 Method and system for indentification of microorganisms |
| 09/15/2011 | US20110224102 Eukaryotic signal sequences for polypeptide expression and polypeptide display libraries |
| 09/15/2011 | US20110224099 Bead bound combinatorial oligonucleoside phosphorothioate and phosphorodithioate aptamer libraries |
| 09/15/2011 | US20110224095 Expression of functional human olfactory cyclic nucleotide gated (CNG) channel in recombinant host cells and use thereof in cell based assays to identify smell modulators |
| 09/15/2011 | US20110224090 SINGLE NUCLEOTIDE POLYMORPHIC MARKERS OF TGFBetaRIII GENE FOR DIAGONISIS OF HEPATOCELLULAR CARCINOMA |
| 09/15/2011 | US20110224089 Gene expression signature of genomic instability in breast cancer |
| 09/15/2011 | US20110224088 Biomarkers for subtypes of cervical cancer |
| 09/15/2011 | US20110223687 Method for diagnosing non-small cell lung cancer |
| 09/15/2011 | US20110223659 Compositions And Methods For Detecting Severe Acute Respiratory Syndrome Coronavirus |
| 09/15/2011 | US20110223656 MicroRNAs and Uses Thereof |
| 09/15/2011 | US20110223634 Transfection kinetics and structural promoters |
| 09/15/2011 | US20110223631 Detection of microorganisms with a fluorescence-based device |
| 09/15/2011 | US20110223630 Method for screening for compounds that inhibit neurodegeneration |
| 09/15/2011 | US20110223629 Method for determination of delta-d values of non- exchangeable hydrogen stable isotopes on ethanol' s methyl group by means of irms instrumental technique |
| 09/15/2011 | US20110223628 METHOD FOR THE IDENTIFICATION OF A RISK FOR A THROMBOGENIC DISORDER BY DETERMINING THE TAFl-lle347 POLYMORPHISM |
| 09/15/2011 | US20110223627 Microfluidic flow assay for measuring hemostatic phenotypes |
| 09/15/2011 | US20110223626 Method for quantitatively determining cholesterol in low-density lipoproteins,reagent for quantitative determination,and quantitative determination kit |
| 09/15/2011 | US20110223625 Bioluminescent assays using cyanobenzothiazole compounds |
| 09/15/2011 | US20110223620 Method of detecting microorganisms and microorganism detecting apparatus |
| 09/15/2011 | US20110223619 Combinations of phosphoinositide 3-kinase inhibitor compounds and chemotherapeutic agents, and methods of use |
| 09/15/2011 | US20110223610 Two secretory luciferases |
| 09/15/2011 | US20110223609 Gene defects and mutant ALK kinase in human solid tumors |